{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T15:22:11Z","timestamp":1793200931561,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>In trigger-free anesthesia a volatile anesthetic concentration of 5 parts per million (ppm) should not be exceeded. According to European Malignant Hyperthermia Group (EMHG) guideline, this may be achieved by removing the vapor, changing the anesthetic breathing circuit and renewing the soda lime canister followed by flushing with O<jats:sub>2<\/jats:sub>or air for a workstation specific time. Reduction of the fresh gas flow (FGF) or stand-by modes are known to cause rebound effects. In this study, simulated trigger-free pediatric and adult ventilation was carried out on test lungs including ventilation maneuvers commonly used in clinical practice. The goal of this study was to evaluate whether rebounds of sevoflurane develop during trigger-free anesthesia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A Dr\u00e4ger\u00ae Primus\u00ae was contaminated with decreasing concentrations of sevoflurane for 120\u00a0min. Then, the machine was prepared for trigger-free anesthesia according to EMHG guideline by changing recommended parts and flushing the breathing circuits using 10 or 18\u00a0l\u22c5min<jats:sup>\u2212\u20091<\/jats:sup>FGF. The machine was neither switched off after preparation nor was FGF reduced. Simulated trigger-free ventilation was performed with volume-controlled ventilation (VCV) and pressure-controlled ventilation (PCV) including various ventilation maneuvers like pressure support ventilation (PSV), apnea, decreased lung compliance (DLC), recruitment maneuvers, prolonged expiration and manual ventilation (MV). A high-resolution ion mobility spectrometer with gas chromatographic pre-separation was used to measure sevoflurane in the ventilation gas mixture in a 20\u00a0s interval.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Immediately after start of simulated anesthesia, there was an initial peak of 11\u201318 ppm sevoflurane in all experiments. The concentration dropped below 5 ppm after 2\u20133\u00a0min during adult and 4\u201318\u00a0min during pediatric ventilation. Other rebounds of sevoflurane\u2009&gt;\u20095 ppm occurred after apnea, DLC and PSV. MV resulted in a decrease of sevoflurane\u2009&lt;\u20095 ppm within 1\u00a0min.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study shows that after guideline-compliant preparation for trigger-free ventilation anesthetic machines may develop rebounds of sevoflurane\u2009&gt;\u20095 ppm during typical maneuvers used in clinical practice. The changes in rate and direction of internal gas flow during different ventilation modes and maneuvers are possible explanations. Therefore, manufacturers should provide machine-specific washout protocols or emphasize the use of active charcoal filters (ACF) for trigger-free anesthesia.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12871-023-02148-3","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T09:02:34Z","timestamp":1686214954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rebounds of sevoflurane concentration during simulated trigger-free pediatric and adult anesthesia"],"prefix":"10.1186","volume":"23","author":[{"given":"Simon","family":"Zumsande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5415-2320","authenticated-orcid":false,"given":"Christian","family":"Thoben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3831-1608","authenticated-orcid":false,"given":"Nils","family":"Dennhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence","family":"Krau\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5850-7443","authenticated-orcid":false,"given":"Robert","family":"S\u00fcmpelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1725-6657","authenticated-orcid":false,"given":"Stefan","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"R\u00fcffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5742-5558","authenticated-orcid":false,"given":"Sebastian","family":"Heiderich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"issue":"9","key":"2148_CR1","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1055\/a-0725-7541","volume":"54","author":"S Johannsen","year":"2019","unstructured":"Johannsen S, Schuster F. [Malignant hyperthermia - update on Pathophysiology, Diagnostics and Treatment]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2019;54(9):527\u201337.","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"2148_CR2","unstructured":"preparation of anesthesia workstations. to anesthetize mh susceptible patients [http:\/\/www.mhaus.org\/healthcare-professionals\/mhaus-recommendations\/preparation-of-anesthesia-workstations-to-anesthetize-mh-susceptible-patients\/]."},{"issue":"1","key":"2148_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bja.2020.09.029","volume":"126","author":"H R\u00fcffert","year":"2021","unstructured":"R\u00fcffert H, Bastian B, Bendixen D, Girard T, Heiderich S, Hellblom A, Hopkins PM, Johannsen S, Snoeck MM, Urwyler A, et al. Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the european malignant Hyperthermia Group. Br J Anaesth. 2021;126(1):120\u201330.","journal-title":"Br J Anaesth"},{"issue":"2","key":"2148_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/00000542-200702000-00017","volume":"106","author":"MW Crawford","year":"2007","unstructured":"Crawford MW, Prinzhausen H, Petroz GC. Accelerating the washout of inhalational anesthetics from the Dr\u00e4ger Primus anesthetic workstation: effect of exchangeable internal components. Anesthesiology. 2007;106(2):289\u201394.","journal-title":"Anesthesiology"},{"issue":"2","key":"2148_CR5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1213\/00000539-198908000-00014","volume":"69","author":"AG Targ","year":"1989","unstructured":"Targ AG, Yasuda N, Eger EI. Solubility of I-653, sevoflurane, isoflurane, and halothane in plastics and rubber composing a conventional anesthetic circuit. Anesth Analg. 1989;69(2):218\u201325.","journal-title":"Anesth Analg"},{"issue":"1","key":"2148_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1213\/ANE.0000000000000208","volume":"119","author":"N Cottron","year":"2014","unstructured":"Cottron N, Larcher C, Sommet A, Fesseau R, Alacoque X, Minville V, Fourcade O, Kern D. The sevoflurane washout profile of seven recent anesthesia workstations for malignant hyperthermia-susceptible adults and infants: a bench test study. Anesth Analg. 2014;119(1):67\u201375.","journal-title":"Anesth Analg"},{"issue":"5","key":"2148_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/EJA.0b013e328351b521","volume":"29","author":"H Shanahan","year":"2012","unstructured":"Shanahan H, O\u2019Donoghue R, O\u2019Kelly P, Synnott A, O\u2019Rourke J. Preparation of the Drager Fabius CE and Drager Zeus anaesthetic machines for patients susceptible to malignant hyperthermia. Eur J Anaesthesiol. 2012;29(5):229\u201334.","journal-title":"Eur J Anaesthesiol"},{"issue":"9","key":"2148_CR8","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/BF03022831","volume":"53","author":"H Prinzhausen","year":"2006","unstructured":"Prinzhausen H, Crawford MW, O\u2019Rourke J, Petroz GC. Preparation of the Dr\u00e4ger Primus anesthetic machine for malignant hyperthermia-susceptible patients. Can J Anaesth. 2006;53(9):885\u201390.","journal-title":"Can J Anaesth"},{"issue":"1","key":"2148_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s12871-021-01533-0","volume":"21","author":"S Heiderich","year":"2021","unstructured":"Heiderich S, Thoben C, Dennhardt N, Krauss T, Sumpelmann R, Zimmermann S, Reitz M, Ruffert H. Preparation of Drager Atlan A350 and General Electric Healthcare Carestation 650 anesthesia workstations for malignant hyperthermia susceptible patients. BMC Anesthesiol. 2021;21(1):315.","journal-title":"BMC Anesthesiol"},{"issue":"11","key":"2148_CR10","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/EJA.0000000000001086","volume":"36","author":"C Thoben","year":"2019","unstructured":"Thoben C, Dennhardt N, Krau\u00df T, S\u00fcmpelmann R, Zimmermann S, R\u00fcffert H, Heiderich S. Preparation of anaesthesia workstation for trigger-free anaesthesia: an observational laboratory study. Eur J Anaesthesiol. 2019;36(11):851\u20136.","journal-title":"Eur J Anaesthesiol"},{"issue":"1","key":"2148_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/ALN.0b013e3181ee2cb7","volume":"114","author":"TW Kim","year":"2011","unstructured":"Kim TW, Nemergut ME. Preparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients: a review of past and present practice. Anesthesiology. 2011;114(1):205\u201312.","journal-title":"Anesthesiology"},{"issue":"3","key":"2148_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/00000542-198809000-00018","volume":"69","author":"JJ Beebe","year":"1988","unstructured":"Beebe JJ, Sessler DI. Preparation of anesthesia machines for patients susceptible to malignant hyperthermia. Anesthesiology. 1988;69(3):395\u2013400.","journal-title":"Anesthesiology"},{"issue":"12","key":"2148_CR13","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/pan.12234","volume":"23","author":"TW Kim","year":"2013","unstructured":"Kim TW, Wingate JR, Fernandez AM, Whitaker E, Tham RQ. Washout times of desflurane, sevoflurane and isoflurane from the GE Healthcare Aisys(R) and avance(R), Carestation(R), and Aestiva(R) anesthesia system. Paediatr Anaesth. 2013;23(12):1124\u201330.","journal-title":"Paediatr Anaesth"},{"issue":"1","key":"2148_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1213\/ANE.0000000000003441","volume":"129","author":"VM Neira","year":"2019","unstructured":"Neira VM, Al Madhoun W, Ghaffari K, Barrowman N, Berrigan P, Splinter W. Efficacy of Malignant Hyperthermia Association of the United States-Recommended methods of Preparation for malignant hyperthermia-susceptible patients using Drager Zeus Anesthesia Workstations and Associated costs. Anesth Analg. 2019;129(1):74\u201383.","journal-title":"Anesth Analg"},{"issue":"15","key":"2148_CR15","doi-asserted-by":"publisher","first-page":"9256","DOI":"10.1021\/acs.analchem.8b01805","volume":"90","author":"MR Wunsch","year":"2018","unstructured":"Wunsch MR, Lehnig R, Janke C, Trapp O. Online High Throughput measurements for fast catalytic reactions using Time-Division Multiplexing Gas Chromatography. Anal Chem. 2018;90(15):9256\u201363.","journal-title":"Anal Chem"},{"issue":"13","key":"2148_CR16","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/j.tetasy.2010.05.029","volume":"21","author":"CJ Welch","year":"2010","unstructured":"Welch CJ, Gong X, Schafer W, Pratt EC, Brkovic T, Pirzada Z, Cuff JF, Kosjek B. MISER chromatography (multiple injections in a single experimental run): the chromatogram is the graph. Tetrahedron: Asymmetry. 2010;21(13):1674\u201381.","journal-title":"Tetrahedron: Asymmetry"},{"key":"2148_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jpba.2013.01.016","volume":"77","author":"R Papp","year":"2013","unstructured":"Papp R, Andersson U, Cantin L-D. Evaluating MISER chromatography for a rapid formulation screen. J Pharm Biomed Anal. 2013;77:94\u20139.","journal-title":"J Pharm Biomed Anal"},{"key":"2148_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.chroma.2017.04.002","volume":"1499","author":"K Zawatzky","year":"2017","unstructured":"Zawatzky K, Barhate CL, Regalado EL, Mann BF, Marshall N, Moore JC, Welch CJ. Overcoming \u201cspeed limits\u201d in high throughput chromatographic analysis. J Chromatogr A. 2017;1499:211\u20136.","journal-title":"J Chromatogr A"},{"issue":"11","key":"2148_CR19","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1007\/s00216-021-03242-6","volume":"413","author":"V Speckbacher","year":"2021","unstructured":"Speckbacher V, Zeilinger S, Zimmermann S, Mayhew CA, Wiesenhofer H, Ruzsanyi V. Monitoring the volatile language of fungi using gas chromatography-ion mobility spectrometry. Anal Bioanal Chem. 2021;413(11):3055\u201367.","journal-title":"Anal Bioanal Chem"},{"key":"2148_CR20","unstructured":"Kramer A, Kranabetter R, Rathgeber J, Z\u00fcchner K, Assadian O, Daeschlein G, H\u00fcbner NO, Dietlein E, Exner M, Gr\u00fcndling M et al. Infection prevention during anaesthesia ventilation by the use of breathing system filters (BSF): joint recommendation by german society of Hospital Hygiene (DGKH) and german society for Anaesthesiology and Intensive Care (DGAI). GMS Krankenhhyg Interdiszip 2010, 5(2)."},{"issue":"4","key":"2148_CR21","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1399-6576.1981.tb01657.x","volume":"25","author":"JA Aldrete","year":"1981","unstructured":"Aldrete JA, Cubillos P, Sherrill D. Humidity and temperature changes during low flow and closed system anaesthesia. Acta Anaesthesiol Scand. 1981;25(4):312\u20134.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"12","key":"2148_CR22","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1002\/humu.23635","volume":"39","author":"IT Zaharieva","year":"2018","unstructured":"Zaharieva IT, Sarkozy A, Munot P, Manzur A, O\u2019Grady G, Rendu J, Malfatti E, Amthor H, Servais L, Urtizberea JA, et al. STAC3 variants cause a congenital myopathy with distinctive dysmorphic features and malignant hyperthermia susceptibility. Hum Mutat. 2018;39(12):1980\u201394.","journal-title":"Hum Mutat"},{"key":"2148_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1750-1172-9-8","volume":"9","author":"W Klingler","year":"2014","unstructured":"Klingler W, Heiderich S, Girard T, Gravino E, Heffron JJ, Johannsen S, Jurkat-Rott K, Ruffert H, Schuster F, Snoeck M, et al. Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study. Orphanet J Rare Dis. 2014;9:8.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"2148_CR24","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1399-6576.2007.01293.x","volume":"51","author":"G Islander","year":"2007","unstructured":"Islander G, Rydenfelt K, Ranklev E, Bodelsson M. Male preponderance of patients testing positive for malignant hyperthermia susceptibility. Acta Anaesthesiol Scand. 2007;51(5):614\u201320.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"2","key":"2148_CR25","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1213\/ANE.0b013e3181c6b9b2","volume":"110","author":"MG Larach","year":"2010","unstructured":"Larach MG, Gronert GA, Allen GC, Brandom BW, Lehman EB. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006. Anesth Analg. 2010;110(2):498\u2013507.","journal-title":"Anesth Analg"},{"issue":"5","key":"2148_CR26","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1097\/ALN.0000000000002813","volume":"131","author":"CA Ibarra Moreno","year":"2019","unstructured":"Ibarra Moreno CA, Hu S, Kraeva N, Schuster F, Johannsen S, Rueffert H, Klingler W, Heytens L, Riazi S. An Assessment of Penetrance and Clinical expression of malignant hyperthermia in individuals carrying diagnostic ryanodine receptor 1 gene mutations. Anesthesiology. 2019;131(5):983\u201391.","journal-title":"Anesthesiology"},{"key":"2148_CR27","doi-asserted-by":"crossref","unstructured":"Riazi S, Bersselaar L, Islander G, Heytens L, Snoeck MMJ, Bjorksten A, Gillies R, Dranitsaris G, Hellblom A, Treves S et al. Pre-operative exercise and pyrexia as modifying factors in malignant hyperthermia (MH). Neuromuscul Disord 2022.","DOI":"10.2139\/ssrn.3760463"},{"issue":"7","key":"2148_CR28","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/EJA.0000000000001399","volume":"38","author":"A Gonzalez","year":"2021","unstructured":"Gonzalez A, Girard T, Dell-Kuster S, Urwyler A, Bandschapp O. BMI and malignant hyperthermia pathogenic ryanodine receptor type 1 sequence variants in Switzerland: a retrospective cohort analysis. Eur J Anaesthesiol. 2021;38(7):751\u20137.","journal-title":"Eur J Anaesthesiol"},{"issue":"5","key":"2148_CR29","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s12630-019-01320-z","volume":"66","author":"E Zvaritch","year":"2019","unstructured":"Zvaritch E, Gillies R, Kraeva N, Richer M, Jungbluth H, Riazi S. Fatal awake malignant hyperthermia episodes in a family with malignant hyperthermia susceptibility: a case series. Can J Anaesth. 2019;66(5):540\u20135.","journal-title":"Can J Anaesth"},{"issue":"2","key":"2148_CR30","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1213\/ANE.0b013e3182768f99","volume":"116","author":"WA Lavezzi","year":"2013","unstructured":"Lavezzi WA, Capacchione JF, Muldoon SM, Sambuughin N, Bina S, Steele D, Brandom BW. Case report: death in the emergency department: an unrecognized awake malignant hyperthermia-like reaction in a six-year-old. Anesth Analg. 2013;116(2):420\u20133.","journal-title":"Anesth Analg"},{"issue":"5","key":"2148_CR31","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1097\/ALN.0b013e318232008f","volume":"115","author":"F Lehmann-Horn","year":"2011","unstructured":"Lehmann-Horn F, Klingler W, Jurkat-Rott K. Nonanesthetic malignant hyperthermia. Anesthesiology. 2011;115(5):915\u20137.","journal-title":"Anesthesiology"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-023-02148-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-023-02148-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-023-02148-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T20:51:29Z","timestamp":1702587089000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-023-02148-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2148"],"URL":"https:\/\/doi.org\/10.1186\/s12871-023-02148-3","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,8]]},"assertion":[{"value":"13 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As there were no humans or animals involved, no ethical approval was necessary for this laboratory technical study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"R. S. received fees for speeches and funds for research from B. Braun Melsungen AG, Melsungen, Germany. SH, CT, ND, TK, SZ, MR and HR have no conflicts of interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"196"}}